Validation of Lipophosphonoxin-loaded Polycaprolactone Nanofiber Dressing for Full-thickness Wounds in a Porcine Model
This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m...
Saved in:
Published in | In vivo (Athens) Vol. 39; no. 3; pp. 1331 - 1340 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Greece
International Institute of Anticancer Research
01.05.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 0258-851X 1791-7549 1791-7549 |
DOI | 10.21873/invivo.13937 |
Cover
Abstract | This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m
) on wound-healing outcomes and validate findings from previous murine studies.
Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level.
Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m
) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m
). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics.
The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application. |
---|---|
AbstractList | This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m2) on wound-healing outcomes and validate findings from previous murine studies.BACKGROUND/AIMThis study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m2) on wound-healing outcomes and validate findings from previous murine studies.Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level.MATERIALS AND METHODSFull-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level.Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m2) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m2). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics.RESULTSMacroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m2) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m2). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics.The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application.CONCLUSIONThe findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application. This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m ) on wound-healing outcomes and validate findings from previous murine studies. Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level. Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m ) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m ). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics. The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application. Background/Aim: This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings (NANO-LPPO) for full-thickness wound healing. Using a porcine model, we aimed to assess the impact of areal weight of the dressing (10, 20 and 30 g/m2) on wound-healing outcomes and validate findings from previous murine studies.Materials and Methods: Full-thickness wounds were created on porcine skin and treated with the NANO-LPPO dressings of differing thickness. Positive control (Aquacel Ag+) and standard control (Jelonet) groups were included for comparison. Wound-healing progression was evaluated macroscopically and on the histological level.Results: Macroscopic observations indicated no signs of infection in any group, with wounds covered by scabs by day 14. Thicker dressings (areal weights of 30 and 20 g/m2) demonstrated superior performance in promoting the formation of granulation tissue and healing compared to the thinner version (areal weight of 10 g/m2). LPPO-loading enhanced scaffold wettability and biodegradability without impairing healing outcomes. Both control groups exhibited similar healing characteristics.Conclusion: The findings underscore the importance of optimizing dressing thickness for effective wound healing. NANO-LPPO dressings exhibit translational potential as a therapeutic option for full-thickness wounds, warranting further preclinical and regulatory evaluation to support clinical application. |
Author | KOŠŤÁKOVÁ, EVA KUŽELOVÁ BOHUŠ, PETER GÁL, PETER JENČOVÁ, VĚRA JUHÁS, ŠTEFAN JUHÁSOVÁ, JANA BALLOVÁ, ZUZANA ZAJÍČEK, ROBERT ŠUCA, HUBERT REJMAN, DOMINIK LUKÁŠ, DAVID |
Author_xml | – sequence: 1 givenname: HUBERT surname: ŠUCA fullname: ŠUCA, HUBERT – sequence: 2 givenname: ŠTEFAN surname: JUHÁS fullname: JUHÁS, ŠTEFAN – sequence: 3 givenname: JANA surname: JUHÁSOVÁ fullname: JUHÁSOVÁ, JANA – sequence: 4 givenname: VĚRA surname: JENČOVÁ fullname: JENČOVÁ, VĚRA – sequence: 5 givenname: EVA KUŽELOVÁ surname: KOŠŤÁKOVÁ fullname: KOŠŤÁKOVÁ, EVA KUŽELOVÁ – sequence: 6 givenname: DAVID surname: LUKÁŠ fullname: LUKÁŠ, DAVID – sequence: 7 givenname: PETER surname: BOHUŠ fullname: BOHUŠ, PETER – sequence: 8 givenname: ZUZANA surname: BALLOVÁ fullname: BALLOVÁ, ZUZANA – sequence: 9 givenname: ROBERT surname: ZAJÍČEK fullname: ZAJÍČEK, ROBERT – sequence: 10 givenname: DOMINIK surname: REJMAN fullname: REJMAN, DOMINIK – sequence: 11 givenname: PETER surname: GÁL fullname: GÁL, PETER |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40294986$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9vFCEcxYmpsdvq0ash8eJltjAwA5yMqbY22aoHf90IwzBdKst3hJmt-99LulWrFw-EhO97L5_v4wgdRIgOoaeULGsqBTvxceu3sKRMMfEALahQtBINVwdoQepGVrKhXw_RUc7XhLSCkPoROuSkVlzJdoG2n03wvZk8RAwDXvkRxjXkciL88LEKYHrX4w8QdtaMCYKxUwHA70yEwXcu4dfJ5ezjFR4g4bM5hGpae_stllf8BebYZ-wjNiUiWV-cl9C78Bg9HEzI7sndfYw-nb35ePq2Wr0_vzh9taosE3yquoJL1cBYQwdlrGytEM5aYzm3fdnGDYxzWXahNWm5aSSTrGs5V6q2dScadoyW-9w5jmZ3Y0LQY_Ibk3aaEn1boN4XqG8LLIaXe8M4dxvXWxenZP6YwHj99yT6tb6CrS4EvCaUloQXdwkJvs8uT3rjs3UhmOhgzppR1bZEFuwiff6P9BrmFEshmtWM8FZK2hbVs_tIv1l-fWIRVHuBTZBzcsN_dvwJQcCxTw |
ContentType | Journal Article |
Copyright | Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. 2025. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2025 The Author(s). Published by the International Institute of Anticancer Research. 2025 |
Copyright_xml | – notice: Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. – notice: 2025. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2025 The Author(s). Published by the International Institute of Anticancer Research. 2025 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY |
DOI | 10.21873/invivo.13937 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-7549 |
EndPage | 1340 |
ExternalDocumentID | 10.21873/invivo.13937 PMC12042011 40294986 10_21873_invivo_13937 |
Genre | Journal Article |
GeographicLocations | Czech Republic United Kingdom--UK Germany Prague Czech Republic |
GeographicLocations_xml | – name: Czech Republic – name: Germany – name: United Kingdom--UK – name: Prague Czech Republic |
GroupedDBID | --- 53G 5GY 5VS 7RV 88E 8FI 8FJ AAYXX AENEX AFKRA ALMA_UNASSIGNED_HOLDINGS CCPQU CITATION DIK EBS EJD EMOBN F5P H13 HMCUK HYE KQ8 NAPCQ OK1 P2P PHGZM PHGZT PJZUB PPXIY PSQYO RHI RPM UKHRP VRB W8F AFOSN CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 8FK ABUWG BENPR FYUFA K9. M1P PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM ADTOC UNPAY |
ID | FETCH-LOGICAL-c374t-b00219f3351f9ac86c77eccac44cd067ef344829412064a58383b644992c2b753 |
IEDL.DBID | 7X7 |
ISSN | 0258-851X 1791-7549 |
IngestDate | Tue Aug 19 23:23:23 EDT 2025 Thu Aug 21 18:26:12 EDT 2025 Fri Sep 05 17:22:26 EDT 2025 Sat Aug 23 13:35:32 EDT 2025 Fri May 16 02:46:58 EDT 2025 Wed Oct 01 05:28:32 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | repair Wound healing active wound dressing regeneration wound treatment skin antibacterial agent |
Language | English |
License | Copyright © 2025, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license cc-by-nc-nd |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c374t-b00219f3351f9ac86c77eccac44cd067ef344829412064a58383b644992c2b753 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC12042011 |
PMID | 40294986 |
PQID | 3230468816 |
PQPubID | 7212310 |
PageCount | 10 |
ParticipantIDs | unpaywall_primary_10_21873_invivo_13937 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12042011 proquest_miscellaneous_3196608482 proquest_journals_3230468816 pubmed_primary_40294986 crossref_primary_10_21873_invivo_13937 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2025-05-01 |
PublicationDateYYYYMMDD | 2025-05-01 |
PublicationDate_xml | – month: 05 year: 2025 text: 2025-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Greece |
PublicationPlace_xml | – name: Greece – name: Highlands |
PublicationTitle | In vivo (Athens) |
PublicationTitleAlternate | In Vivo |
PublicationYear | 2025 |
Publisher | International Institute of Anticancer Research |
Publisher_xml | – name: International Institute of Anticancer Research |
SSID | ssj0067002 |
Score | 2.3917716 |
Snippet | This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber dressings... Background/Aim: This study investigated the therapeutic potential of lipophosphonoxin (LPPO), an antibacterial agent, loaded into polycaprolactone nanofiber... |
SourceID | unpaywall pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 1331 |
SubjectTerms | Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology Bacterial infections Bandages Biocompatibility Biodegradation Collagen Disease Models, Animal Ethanol Experiments Histology Infections Lipoxins - administration & dosage Lipoxins - chemistry Lipoxins - pharmacology Nanofibers - chemistry Physiology Polyesters - chemistry Skin - drug effects Skin - pathology Swine Wound healing Wound Healing - drug effects |
Title | Validation of Lipophosphonoxin-loaded Polycaprolactone Nanofiber Dressing for Full-thickness Wounds in a Porcine Model |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40294986 https://www.proquest.com/docview/3230468816 https://www.proquest.com/docview/3196608482 https://pubmed.ncbi.nlm.nih.gov/PMC12042011 https://iv.iiarjournals.org/content/invivo/39/3/1331.full.pdf |
UnpaywallVersion | publishedVersion |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1791-7549 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067002 issn: 1791-7549 databaseCode: KQ8 dateStart: 20040101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1791-7549 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067002 issn: 1791-7549 databaseCode: RPM dateStart: 20170101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglaAXxJtAWRkJwcl0EzuJfUI8WlUIqgpR2FvkOA6NiOx0X9B_z4yTDawq9RjlZftzPN94JvMR8nJa55JX05oZUwsGFkIwKYRgSmiruOC8LEO2xUl2fCY-zdLZsOG2GNIqN2tiWKgrb3CP_IDj7mUmZZy97S4YqkZhdHWQ0LhJdmOgKjir89nocOEfKCGKkKSSAbOY9TU2wajl_KBx62bt38RYEG7bJl0hmlfzJW-vXKcvf-u2_c8YHd0ldwYWSd_1sN8jN6y7T259GeLkD8j6O9DrXi2J-pp-bjrfnfsF5qH7P41jrdeVreipby-Nhpa0qLrjLIW1FiZbaef0Y8iPdT8pkFqKfirDxPhfuDDSHyjFtKCNoxoeMcdXUtRUax-Ss6PDbx-O2aCwwAzPxZIFE69qztO4VtrIzOQ5YmqEMBWMn605uG-JEnEC1EVjiJWXwKCUSkxSgqfziOw4aN4TQnOdVtlU2TxLBarWaalrOAS6qaaV5DwirzZjXHR9IY0CHJAARtGDUQQwIrK_QaAYvqdF8Q_9iLwYT8OXgOEN7axfwTUxVhqV0N6IPO4BG98EXrISSsLdcgvK8QKssr19xjXnodo2dF0gS4rI6xH163vw9PoePCN7CYoIh6zJfbKznK_sc2A2y3ISpu-E7L4_PDn9OglbT38BU6D8gA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlEuiDcpBYzE42S6iZ3EPiCEKNWWbisOLewtdRyHRkROuq-yf4rfyEyyCawq9dZjlJedGc9845nMR8jrQR5Lng1yZkwuGHgIwaQQgimhreKC8zRtqi2Oo-Gp-DoOxxvkT_cvDJZVdjaxMdRZZXCPfJfj7mUkpR99rC8YskZhdrWj0GjV4tAuLyFkm3442AP5vgmC_S8nn4dsxSrADI_FjDVuTeWch36utJGRiWOchxHCZGC7bc4hZAmU8ANw1xrTijwF1KBUYII0RpYIMPm3BAwHe_XH4z7Awz9emqxFEEoGSGbc9vQEJxrz3cItikX13scGdOs-8AqwvVqfuTV3tV5e6rL8z_nt3yN3V6iVfmrV7D7ZsO4BuX20yss_JIvvAOdbdiZa5XRU1FV9Xk2x7r36XThWVjqzGf1WlUujYSQlsvw4S8G2g3KndkL3mnpc95MCiKYYFzMsxP-Fhpj-QOqnKS0c1fCICb6SIodb-Yic3si3f0w2HQzvKaGxDrNooGwchQJZ8rTUORwCvFWDTHLukbfdN07qtnFHAgFPI4ykFUbSCMMjO50EktX6nSb_tM0jr_rTsPIwnaKdreZwjY-dTSWM1yNPWoH1b4KoXAkl4W65Jsr-AuzqvX7GFedNd2-YukBU5pF3vdSvn8H29TN4SbaGJ0ejZHRwfPiM3AmQwLip2Nwhm7PJ3D4HVDVLXzSqTMnZTa-dvwPRNLU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+Lipophosphonoxin-loaded+Polycaprolactone+Nanofiber+Dressing+for+Full-thickness+Wounds+in+a+Porcine+Model&rft.jtitle=In+vivo+%28Athens%29&rft.au=%C5%A0uca%2C+Hubert&rft.au=Juh%C3%A1s%2C+%C5%A0tefan&rft.au=Juh%C3%A1sov%C3%A1%2C+Jana&rft.au=Jen%C4%8Dov%C3%A1%2C+V%C4%9Bra&rft.date=2025-05-01&rft.issn=1791-7549&rft.eissn=1791-7549&rft.volume=39&rft.issue=3&rft.spage=1331&rft_id=info:doi/10.21873%2Finvivo.13937&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0258-851X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0258-851X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0258-851X&client=summon |